Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 9:25 AM ET


Company Overview of Yeda Research and Development Company Ltd.

Company Overview

Yeda Research and Development Company Ltd., a technology transfer company, markets and commercializes intellectual properties that are created in the laboratories of Weizmann Institute of Science. The company identifies and assesses research projects with commercial potential, protects the intellectual property of the institute and its scientists, licenses the institute’s inventions and technologies to industry, and channels funding from industry to research projects. It markets and commercializes intellectual properties that cover a range of natural sciences, including biotechnology, pharmaceuticals, and diagnostics; bioinformatics, proteomics, biomatics, and system biology; medical devices...

Weizman Institue of Science

de Botton Building (Building No. 5)

P.O. Box 95

Rehovot,  76100


Founded in 1959


972 8 947 0617


972 8 947 0739

Key Executives for Yeda Research and Development Company Ltd.

Chief Executive Officer
Chief Financial Officer
Chief Intellectual Property Officer
Chif Business Officer
General Counsel
Compensation as of Fiscal Year 2015.

Yeda Research and Development Company Ltd. Key Developments

TxCell SA Enters into Exclusive Option Agreement with Yeda Research and Development

TxCell SA announced that it has entered into an exclusive option agreement with Yeda Research and Development Co. Ltd. Resulting from the exclusive option agreement, TxCell will gain exclusive access to a CAR-Treg patent for suppression of autoimmune and inflammatory diseases originated in the Weizmann Institute of Science laboratory of Professor Zelig Eshhar. The patent application under the option that TxCell has obtained covers redirected, genetically engineered T regulatory cells (CAR-Treg) and their use in suppression of autoimmune and inflammatory diseases. The option agreement grants TxCell until June 30, 2016 to opt-in at predefined terms.

Yeda Presents at BIO-Europe 2015, Nov-03-2015 02:50 PM

Yeda Presents at BIO-Europe 2015, Nov-03-2015 02:50 PM. Venue: Munich, Germany.

XTL Biopharmaceuticals Announces Agreement with Yeda Research and Development Company Ltd to Amend License

XTL Biopharmaceuticals Ltd. announced that it has reached agreement with Yeda Research and development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE). The amended agreement extends the time for achievement of key development milestones by approximately five additional months including delivery to Yeda of a full protocol for an upcoming clinical trial on hCDR1, raising an aggregate of USD 5 million and commencing a clinical trial on hCDR1 by January 2017. The amended agreement recognizes XTL's efforts to date to advance hCDR1to a clinical trial including assembling a world-class Clinical Advisory Board with leading names in SLE, strengthening the Company's Board with Directors with drug development and financial market experience, transferring the IND relating to hCDR1from Teva Pharmaceutical Industries Limited to the Company, manufacturing the drug substance for the upcoming trial, engaging in ongoing discussions with the FDA to seek opportunities to strengthen hCDR1intellectual property and optimize the regulatory pathway, and raising USD 4 million out of the aggregate amount of USD 5 million as required by the License Agreement.

Similar Private Companies By Industry

Company Name Region
The T.B.N. Group Ltd. Middle East/Africa
Globes Publisher Itonut (1983) Ltd. Middle East/Africa
The Box Middle East/Africa
Wolf Communications & Public Relations Middle East/Africa
Blue-Goo Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Yeda Research and Development Company Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at